198 related articles for article (PubMed ID: 6128769)
1. Citalopram--pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity.
Hyttel J
Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):277-95. PubMed ID: 6128769
[TBL] [Abstract][Full Text] [Related]
2. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171.
Hyttel J
Psychopharmacology (Berl); 1977 Mar; 51(3):225-33. PubMed ID: 403537
[TBL] [Abstract][Full Text] [Related]
3. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.
Arnt J; Hyttel J; Overø KF
Pol J Pharmacol Pharm; 1984; 36(2-3):221-30. PubMed ID: 6591152
[TBL] [Abstract][Full Text] [Related]
4. The citalopram/5-HTP-induced head shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmitters.
Arnt J; Hyttel J; Larsen JJ
Acta Pharmacol Toxicol (Copenh); 1984 Nov; 55(5):363-72. PubMed ID: 6152104
[TBL] [Abstract][Full Text] [Related]
5. Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro.
Hyttel J
Psychopharmacology (Berl); 1978 Dec; 60(1):13-8. PubMed ID: 104340
[TBL] [Abstract][Full Text] [Related]
6. Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram.
Hyttel J; Overø KF; Arnt J
Psychopharmacology (Berl); 1984; 83(1):20-7. PubMed ID: 6429698
[TBL] [Abstract][Full Text] [Related]
7. Effect of citalopram (Lu 10-171) on tranylcypromine and tryptophan-induced wet-dog shakes in rats.
Keshavan HJ; Gurbani NK; Dandiya PC
Psychopharmacology (Berl); 1980; 70(2):209-12. PubMed ID: 6159662
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and pharmacological evaluation of the novel antidepressant and serotonin uptake inhibitor 2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol hydrochloride.
Gouret CJ; Porsolt R; Wettstein JG; Puech A; Soulard C; Pascaud X; Junien JL
Arzneimittelforschung; 1990 Jun; 40(6):633-40. PubMed ID: 2168703
[TBL] [Abstract][Full Text] [Related]
9. Effect of a specific 5HT uptake inhibitor (citalopram) on drug accumulation by rat lung slices.
Drew R; Siddik ZH
Pharmacology; 1980; 20(1):27-31. PubMed ID: 6929555
[TBL] [Abstract][Full Text] [Related]
10. Serotonin uptake inhibitors and the prejunctional effects of serotonin on peripheral sympathetic nerves.
Adler-Graschinsky E; Butta NV; Elgoyhen AB
Life Sci; 1986 Jul; 39(1):61-8. PubMed ID: 3487690
[TBL] [Abstract][Full Text] [Related]
11. Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram.
Arnt J; Overø KF; Hyttel J; Olsen R
Psychopharmacology (Berl); 1984; 84(4):457-65. PubMed ID: 6441945
[TBL] [Abstract][Full Text] [Related]
12. Antidepressants and serotonin neurons of the raphe.
Constantinidis J; Dick P; Tissot R
Neuropsychobiology; 1981; 7(3):113-21. PubMed ID: 6785659
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and pharmacological tests for the prediction of ability of monoamine uptake blockers to inhibit the uptake of noradrenaline in-vivo: the effects of desipramine, maprotiline, femoxetine and citalopram.
Pawłowski L; Nowak G
J Pharm Pharmacol; 1987 Dec; 39(12):1003-9. PubMed ID: 2894425
[TBL] [Abstract][Full Text] [Related]
14. 5-HT-uptake inhibition potentiates antinociception induced by morphine, pethidine, methadone and ketobemidone in rats.
Larsen JJ; Hyttel J
Acta Pharmacol Toxicol (Copenh); 1985 Sep; 57(3):214-8. PubMed ID: 2865865
[TBL] [Abstract][Full Text] [Related]
15. The effect of selective inhibitors of noradrenaline and serotonin uptake on reserpine- and apomorphine induced hypothermia in mice.
Maj J; Rogóz Z; Skuza G; Sowińska H
Pol J Pharmacol Pharm; 1983; 35(1):49-57. PubMed ID: 6604264
[TBL] [Abstract][Full Text] [Related]
16. Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities.
Pawlowski L; Nowak G; Górka Z; Mazela H
Psychopharmacology (Berl); 1985; 86(1-2):156-63. PubMed ID: 3927352
[TBL] [Abstract][Full Text] [Related]
17. CNS effects of citalopram, a new serotonin inhibitor antidepressant (a quantitative pharmaco-electroencephalography study).
Itil TM; Menon GN; Bozak MM; Itil KZ
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(3):397-409. PubMed ID: 6592676
[TBL] [Abstract][Full Text] [Related]
18. Spinal 5-HT or NA uptake inhibition potentiates supraspinal morphine antinociception in rats.
Larsen JJ; Arnt J
Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):72-5. PubMed ID: 6583982
[TBL] [Abstract][Full Text] [Related]
19. Preliminary studies with citalopram (LU 10-171), a specific 5-HT-reuptake inhibitor, as antidepressant.
Gastpar M; Gastpar G
Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):319-25. PubMed ID: 6959196
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical profile of Lu 19-005, a potent inhibitor of uptake of dopamine, noradrenaline, and serotonin.
Hyttel J; Larsen JJ
J Neurochem; 1985 May; 44(5):1615-22. PubMed ID: 2580950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
